Holen Sie sich die Stockscreener-App
15.18
0.79%
-0.121
Schlusskurs vom Vortag:
$15.30
Offen:
$15.32
24-Stunden-Volumen:
38,121
Relative Volume:
0.03
Marktkapitalisierung:
$120.53M
Einnahmen:
$49.09M
Nettoeinkommen (Verlust:
$-52.15M
KGV:
-23.35
EPS:
-0.65
Netto-Cashflow:
$-45.93M
1W Leistung:
+6.74%
1M Leistung:
+52.40%
6M Leistung:
+71.94%
1J Leistung:
-12.76%
1-Tages-Spanne:
$15.04
$15.86
1-Wochen-Bereich:
$14.23
$17.40
52-Wochen-Spanne:
$3.436
$18.48
Biodesix Inc Stock (BDSX) Company Profile
Firmenname
Biodesix Inc
Sektor
Branche
Telefon
303-417-0500
Adresse
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
15.15 | 121.72M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
511.75 | 192.62B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
202.03 | 144.77B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
619.85 | 51.65B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
118.23 | 34.09B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.90 | 31.30B | 3.17B | 642.63M | 516.49M | 10.77 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-07-26 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-13 | Eingeleitet | TD Cowen | Buy |
| 2024-05-03 | Eingeleitet | Lake Street | Buy |
| 2021-11-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | Eingeleitet | BTIG Research | Buy |
| 2020-11-23 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-23 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-23 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Biodesix Inc Aktie (BDSX) Neueste Nachrichten
Wall Street experts predict that Biodesix (BDSX) may climb by 111.62%: Consider this information before making an investment decision - Bitget
Wall Street Analysts Think Biodesix (BDSX) Could Surge 111.62%: Read This Before Placing a Bet - Finviz
Are Medical Stocks Lagging Biodesix (BDSX) This Year? - Yahoo Finance
BDSX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Monashee Investment Management Cuts Biodesix Stake by 95% - National Today
Are healthcare stocks underperforming Biodesix (BDSX) so far this year? - Bitget
Canaccord reiterates Biodesix stock rating on strong Q4 results - Investing.com
Canaccord reiterates Biodesix stock rating on strong Q4 results By Investing.com - Investing.com UK
Biodesix (BDSX) Q4 2025 Earnings Call Transcript - AOL.com
Monashee Investment Management LLC Cuts Holdings in Biodesix, Inc. $BDSX - MarketBeat
Q4 2025 Biodesix Inc Earnings Call Transcript - GuruFocus
William Blair Upgrades Biodesix (BDSX) - Nasdaq
William Blair Upgrades BDSX (Biodesix, Inc.) to Outperform Feb 2026 - Meyka
Biodesix (NASDAQ:BDSX) Announces Quarterly Earnings Results, Beats Estimates By $0.56 EPS - MarketBeat
William Blair Upgrades Biodesix (BDSX) to 'Outperform' | BDSX St - GuruFocus
Biodesix expects 2026 sales to crack $100M - BizWest
Biodesix, Inc. (BDSX) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
William Blair Upgrades Biodesix to Outperform From Market Perform - marketscreener.com
GSA Capital Partners LLP Has $365,000 Stake in Biodesix, Inc. $BDSX - MarketBeat
William Blair upgrades Biodesix stock rating on execution momentum By Investing.com - Investing.com Australia
William Blair upgrades Biodesix stock rating on execution momentum - Investing.com South Africa
Biodesix Inc (BDSX) Q4 2025 Earnings Call Highlights: Strong Rev - GuruFocus
Biodesix, Inc. Q4 Loss Drops - Nasdaq
Biodesix Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Biodesix Q4 2025 shows strong revenue growth and positive EBITDA - Investing.com Nigeria
BDSX Projects 80% Gross Margin and Revenue Growth for FY26 - GuruFocus
Biodesix Inc (NASDAQ:BDSX) Reports Q4 2025 Earnings Beat and First Adjusted EBITDA Profitability - ChartMill
Biodesix Q4 Earnings Call Highlights - MarketBeat
Biodesix (BDSX) Surpasses Revenue Expectations in Q4 with 41% Gr - GuruFocus
Biodesix, Inc. (BDSX) Reports Q4 Loss, Beats Revenue Estimates - Nasdaq
Biodesix Inc. (BDSX) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Biodesix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights - TradingView
Biodesix (NASDAQ: BDSX) hits first positive EBITDA on 41% Q4 growth - Stock Titan
BRIEF-Biodesix Q4 Adjusted Operating Expenses USD 25.8 Million - TradingView
Biodesix, Inc. (BDSX) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget
Earnings To Watch: Biodesix Inc (BDSX) Reports Q4 2025 Result - GuruFocus
Biodesix to Participate in Upcoming Investor Conferences - Caledonian Record
Biodesix management to speak at TD Cowen and Barclays events - Stock Titan
Insider Selling: Biodesix (NASDAQ:BDSX) CEO Sells 1,490 Shares of Stock - MarketBeat
Biodesix officer Pestano sells $7103 in BDSX stock By Investing.com - Investing.com Australia
O’Kane, Biodesix CCO, sells $6834 in BDSX stock - Investing.com South Africa
O’Kane, Biodesix CCO, sells $6834 in BDSX stock By Investing.com - Investing.com Canada
Cowie, Biodesix CFO, sells $6834 in BDSX stock - Investing.com
Biodesix officer Pestano sells $7103 in BDSX stock - Investing.com
Tax-driven Biodesix (BDSX) insider trades follow RSU vesting events - Stock Titan
BDSX (NASDAQ: BDSX) settles 4,844 RSUs; insider Scott Hutton sold shares - Stock Titan
Telemark Asset Management LLC Trims Position in Biodesix, Inc. $BDSX - MarketBeat
Can Biodesix Inc. stock sustain market leadershipTrade Risk Report & Free Fast Entry Momentum Trade Alerts - mfd.ru
Can Biodesix Inc. expand into new marketsBull Run & High Conviction Trade Alerts - mfd.ru
Earnings Miss: How volatile is FBRTPRE stockTrade Analysis Summary & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Finanzdaten der Biodesix Inc-Aktie (BDSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.56%
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):